Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.53 |
| ▸ | TDO2 | P48775 | 1/20 | 0.53 |
| ▸ | IDO2 | Q6ZQW0 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.53 |
| ▸ | PTPN5 | P54829 | 4/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | HTR7 | P34969 | 1/20 | 0.45 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1981717 | 0.85 | TP53 (0.48) | SLC6A2SLC6A4SLC6A3PTPN5 | |
| SCHEMBL28999637 | 0.82 | IDO1 (0.41) | IDO1TDO2IDO2SLC6A2SLC6A4 | |
| SCHEMBL28999639 | 0.82 | CNR2 (0.43) | SLC6A2SLC6A4SLC6A3KCNH2CYP3A4 | |
| SCHEMBL28999627 | 0.82 | SLC6A4 (0.43) | SLC6A2SLC6A4SLC6A3KCNH2CYP3A4 | |
| SCHEMBL17064807 | 0.82 | CA1 (0.44) | IDO1TDO2IDO2SLC6A2SLC6A4 | |
| SCHEMBL28999628 | 0.81 | PTPN5 (0.48) | SLC6A2SLC6A4SLC6A3KCNH2CYP3A4 | |
| SCHEMBL11642246 | 0.81 | PTPN5 (0.48) | SLC6A2SLC6A4SLC6A3KCNH2CYP3A4 | |
| SCHEMBL8671295 | 0.79 | SMN1; SMN2 (0.58) | CYP2D6 | |
| SCHEMBL15647693 | 0.78 | SMN1; SMN2 (0.61) | SLC6A2SLC6A4SLC6A3KCNH2CYP3A4 | |
| SCHEMBL17802412 | 0.78 | SLC6A2 (0.49) | IDO1TDO2IDO2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119243184-A | Electrochemical organic synthesis method of benzyl alcohol fluorinated product by using sulfur hexafluoride as fluorination reagent | 国网安徽省电力有限公司电力科学研究院 | 2025-01-03 | — | — | CN | claimed |
| CN-113387799-B | Preparation method of gamma, gamma-diaryl ester or gamma, gamma-triaryl ester compound and product thereof | 南京工业大学 | 2021-12-21 | — | — | CN | claimed |
| CN-113387799-A | Preparation method of gamma, gamma-diaryl ester or gamma, gamma-triaryl ester compound and product thereof | 南京工业大学 | 2021-09-14 | — | — | CN | claimed |
| CN-119243184-B | Electrochemical organic synthesis method of benzyl alcohol fluorinated product by using sulfur hexafluoride as fluorination reagent | 国网安徽省电力有限公司电力科学研究院 | 2025-11-11 | — | — | CN | disclosed |
| CN-119243184-A | Electrochemical organic synthesis method of benzyl alcohol fluorinated product by using sulfur hexafluoride as fluorination reagent | 国网安徽省电力有限公司电力科学研究院 | 2025-01-03 | — | — | CN | disclosed |
| CN-119243184-A | Electrochemical organic synthesis method of benzyl alcohol fluorinated product by using sulfur hexafluoride as fluorination reagent | 国网安徽省电力有限公司电力科学研究院 | 2025-01-03 | — | — | CN | disclosed |
| CN-113387799-B | Preparation method of gamma, gamma-diaryl ester or gamma, gamma-triaryl ester compound and product thereof | 南京工业大学 | 2021-12-21 | — | — | CN | disclosed |
| CN-113387799-A | Preparation method of gamma, gamma-diaryl ester or gamma, gamma-triaryl ester compound and product thereof | 南京工业大学 | 2021-09-14 | — | — | CN | disclosed |
| US-20210093618-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2021-04-01 | — | — | US | disclosed |
| US-20210093618-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2021-04-01 | — | — | US | disclosed |
| US-20200108054-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2020-04-09 | — | — | US | disclosed |
| US-20040259912-A1 | Benzine derivatives, process for preparing the same and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-12-23 | — | — | US | disclosed |
| EP-1437344-A1 | BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2004-07-14 | — | — | EP | disclosed |
| US-5116988-A | Antiepileptic | WARNER-LAMBERT CO. (US) | 1992-05-26 | — | — | US | disclosed |
| US-5053521-A | 3-amino butyric acid uptake inhibitors, antiepileptic agents | WARNER-LAMBERT COMPANY (US) | 1991-10-01 | — | — | US | disclosed |
| EP-0221572-B1 | N-SUBSTITUTED 3-PIPERIDINE-OR 3-PYRIDINE-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | WARNER-LAMBERT COMPANY (US) | 1991-09-25 | — | — | EP | disclosed |
| US-4910312-A | Containing 1-(2-(bis((4-trifluoromethylphenyl)methoxy)-ethyl)-substitution | WARNER-LAMBERT COMPANY (US) | 1990-03-20 | — | — | US | disclosed |
| EP-0346927-A2 | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridine-carboxylic acids and derivatives thereof | WARNER-LAMBERT COMPANY (US) | 1989-12-20 | — | — | EP | disclosed |
| US-4772615-A | ANTICONVULSANT FOR TREATING EPILEPSY | WARNER-LAMBERT COMPANY (US) | 1988-09-20 | — | — | US | disclosed |
| EP-0221572-A2 | N-substituted 3-piperidine-or 3-pyridine-carboxylic acids and derivatives thereof | WARNER-LAMBERT COMPANY (US) | 1987-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210093618-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | BRIX1, RDX, SULT2A1 | IDO1 2403/4885TDO2 3264/4885IDO2 2404/4885 |
| US-20040259912-A1 | Benzine derivatives, process for preparing the same and use thereof | HRH4, HRH2, HRH1 | IDO1 953/4885TDO2 675/4885IDO2 1385/4885 |
| US-20200108054-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | BRIX1, RDX, SULT2A1 | IDO1 2403/4885TDO2 3264/4885IDO2 2404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.